GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » E10

COTQF (Cotinga Pharmaceuticals) E10 : $-0.35 (As of Jan. 2020)


View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Cotinga Pharmaceuticals's adjusted earnings per share data for the three months ended in Jan. 2020 was $-0.015. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.35 for the trailing ten years ended in Jan. 2020.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-09-24), Cotinga Pharmaceuticals's current stock price is $0.0001. Cotinga Pharmaceuticals's E10 for the quarter that ended in Jan. 2020 was $-0.35. Cotinga Pharmaceuticals's Shiller PE Ratio of today is .


Cotinga Pharmaceuticals E10 Historical Data

The historical data trend for Cotinga Pharmaceuticals's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals E10 Chart

Cotinga Pharmaceuticals Annual Data
Trend Apr10 Apr11 Apr12 Apr13 Apr14 Apr15 Apr16 Apr17 Apr18 Apr19
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.41 -0.43 -0.42 -0.37 -0.36

Cotinga Pharmaceuticals Quarterly Data
Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.30 -0.36 -0.18 -0.38 -0.35

Competitive Comparison of Cotinga Pharmaceuticals's E10

For the Biotechnology subindustry, Cotinga Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cotinga Pharmaceuticals's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's Shiller PE Ratio falls into.



Cotinga Pharmaceuticals E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Cotinga Pharmaceuticals's adjusted earnings per share data for the three months ended in Jan. 2020 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jan. 2020 (Change)*Current CPI (Jan. 2020)
=-0.015/108.0853*108.0853
=-0.015

Current CPI (Jan. 2020) = 108.0853.

Cotinga Pharmaceuticals Quarterly Data

per share eps CPI Adj_EPS
201004 -0.199 91.651 -0.235
201007 -0.096 92.283 -0.112
201010 -0.098 92.757 -0.114
201101 -0.101 93.074 -0.117
201104 -0.104 94.654 -0.119
201107 -0.105 94.812 -0.120
201110 -0.098 95.444 -0.111
201201 -0.099 95.365 -0.112
201204 -0.101 96.550 -0.113
201207 -0.099 95.997 -0.111
201210 -0.101 96.550 -0.113
201301 -0.101 95.839 -0.114
201304 0.000 96.945 0.000
201307 -0.096 97.261 -0.107
201310 -0.096 97.182 -0.107
201401 -0.091 97.261 -0.101
201404 -0.091 98.920 -0.099
201407 -0.093 99.315 -0.101
201410 -0.089 99.473 -0.097
201501 -0.082 98.209 -0.090
201504 -0.081 99.710 -0.088
201507 -0.078 100.579 -0.084
201510 -0.076 100.500 -0.082
201601 -0.070 100.184 -0.076
201604 -0.148 101.370 -0.158
201607 -0.123 101.844 -0.131
201610 -0.038 102.002 -0.040
201701 -0.061 102.318 -0.064
201704 -0.097 103.029 -0.102
201707 -0.016 103.029 -0.017
201710 -0.087 103.424 -0.091
201801 -0.064 104.056 -0.066
201804 -0.079 105.320 -0.081
201807 -0.030 106.110 -0.031
201810 -0.015 105.952 -0.015
201901 -0.008 105.557 -0.008
201904 -0.030 107.453 -0.030
201907 -0.015 108.243 -0.015
201910 -0.015 107.927 -0.015
202001 -0.015 108.085 -0.015

Add all the adjusted EPS together and divide 10 will get our e10.


Cotinga Pharmaceuticals  (OTCPK:COTQF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Cotinga Pharmaceuticals E10 Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Cotinga Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1
Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals Headlines

From GuruFocus

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire 05-22-2019